תבנית:תרופה/דיאנה 35 - Diane 35
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | *Cyproterone acetate 2MG âG03HB01
|
| צ×רת ××ª× | PER OS |
| צ×רת ××× ×× | TABLETS |
| ×ת×××× | Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. For the treatment of acne, Diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/×××× × 35 - Diane 35 | |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר××§×××× ×××§× | Pharmacodynamic Properties |
| פר××§××§×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× | |
| ×¢××× ×צר×× | ×¢××× ×צר×× |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××× × 35 ® ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | BAYER WEIMAR GMBH UND CO.KG, GERMANY |
| ×©× ××¢× ×ר×ש×× | BAYER ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 05/2013. ר×ש××× ×ת×ר××: 05/2013 |
| ת×ר×× ×¢×××× ××ר×× | 02/07/15 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ×××× × 35 - Diane 35
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/×××× × 35 - Diane 35}}
×:
{{תר×פ×/×××× × 35 - Diane 35
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־2 ביולי 2015 ב־02:02